This educational event benefits from an outstanding international faculty who will provide updates in diagnostic and monitoring technology, impact of mutations in genes other than BCR::ABL1 on treatment choices and prognosis, clinical trial results and upcoming clinical trials available in the UK, management of complex patients, mitigating adverse events, expanding eligibility to successful treatment discontinuation, role of allogeneic stem cell transplantation in CML and approaches to facilitating parenting.
It also provides an opportunity to celebrate the 2025 retirements of two UK haematologists with specific interests in CML, Professors Jane Apperley and Nicholas Cross. At the end of the meeting they will provide their insights on developing careers in haematology and CML.
For the full programme and registration form please contact Amanda Smith at [email protected]